• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药磁性介孔栓塞微球在肝癌经导管动脉化疗栓塞术中的应用

Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.

机构信息

Department of Interventional Therapy, Department of Radiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, Jiangsu, PR China.

College of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, PR China.

出版信息

Acta Biomater. 2021 Aug;130:374-384. doi: 10.1016/j.actbio.2021.05.031. Epub 2021 May 31.

DOI:10.1016/j.actbio.2021.05.031
PMID:34082098
Abstract

Transcatheter arterial chemoembolization (TACE) is the main treatment for liver cancer. Although many embolic agents have been exploited in TACE, embolic agents combining embolization, drug loading, and imaging properties have not yet been constructed. Herein, we report a new magnetic mesoporous embolic microsphere that can simultaneously be loaded with doxorubicin (Dox), block vessels, and be observed by magnetic resonance imaging (MRI). The microspheres were prepared by decorating magnetic polystyrene/FeO particles with mesoporous organosilica microparticles (denoted as PS/FeO@MONs). The PS/FeO@MONs were uniformly spherical and large (50 µm), with a high specific surface area, uniform mesopores, and a Dox loading capacity of 460.8 µg mg. Dox-loaded PS/FeO@MONs (PS/FeO@MON@Dox) effectively inhibited liver cancer cell growth. A VX2 rabbit liver tumor model was constructed to study the efficacy of TACE with PS/FeO@MON@Dox. In vivo, PS/FeO@MON@Dox could be smoothly delivered through an arterial catheter to achieve chemoembolization. Moreover, PS/FeO@MON@Dox and residual tumor parenchyma could be distinguished on MRI, which is of great significance for evaluating the efficacy of TACE. Histopathology showed that PS/FeO@MON@Dox could be deposited in the tumor vessels, completely blocking the blood supply. Overall, PS/FeO@MON@Dox showed good drug loading, embolization and imaging performance as well as potential for use in TACE. STATEMENT OF SIGNIFICANCE: Transcatheter arterial chemoembolization (TACE) is the main treatment for liver cancer. Although many embolic agents have been exploited in TACE, embolic agents combining embolization, drug-loading, and imaging properties have not yet been constructed. In this work, we prepared magnetic mesoporous microspheres as a new embolic agent that can simultaneously load doxorubicin (Dox), block blood vessels and enable magnetic resonance imaging. Overall, this new embolic microsphere-mediated TACE strategy for liver cancer showed good therapeutic effects, and the PS/FeO@MON@Dox embolic microspheres provide a new avenue for improving the efficacy of TACE for liver cancer and postoperative evaluation.

摘要

经导管动脉化疗栓塞术(TACE)是肝癌的主要治疗方法。虽然 TACE 中已经开发了许多栓塞剂,但尚未构建具有栓塞、药物负载和成像特性相结合的栓塞剂。在此,我们报告了一种新的磁性介孔栓塞微球,它可以同时负载多柔比星(Dox)、阻断血管并通过磁共振成像(MRI)观察。该微球是通过用介孔有机硅微球(表示为 PS/FeO@MONs)修饰磁性聚苯乙烯/FeO 颗粒制备的。PS/FeO@MONs 呈均匀球形且较大(50 µm),具有高比表面积、均匀的介孔和 460.8 µg mg 的 Dox 载药量。负载 Dox 的 PS/FeO@MONs(PS/FeO@MON@Dox)有效抑制肝癌细胞生长。构建 VX2 兔肝癌模型研究 PS/FeO@MON@Dox 的 TACE 疗效。在体内,PS/FeO@MON@Dox 可通过动脉导管顺利输送以实现化疗栓塞。此外,PS/FeO@MON@Dox 和残留肿瘤实质可在 MRI 上区分,这对于评估 TACE 的疗效具有重要意义。组织病理学显示 PS/FeO@MON@Dox 可沉积在肿瘤血管中,完全阻断血液供应。总体而言,PS/FeO@MON@Dox 表现出良好的载药、栓塞和成像性能,具有用于 TACE 的潜力。

意义声明

经导管动脉化疗栓塞术(TACE)是肝癌的主要治疗方法。虽然 TACE 中已经开发了许多栓塞剂,但尚未构建具有栓塞、药物加载和成像性能相结合的栓塞剂。在这项工作中,我们制备了磁性介孔微球作为一种新的栓塞剂,它可以同时负载多柔比星(Dox)、阻断血管并进行磁共振成像。总体而言,这种新的栓塞微球介导的肝癌 TACE 策略显示出良好的治疗效果,PS/FeO@MON@Dox 栓塞微球为提高肝癌 TACE 疗效和术后评估提供了新途径。

相似文献

1
Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.载药磁性介孔栓塞微球在肝癌经导管动脉化疗栓塞术中的应用
Acta Biomater. 2021 Aug;130:374-384. doi: 10.1016/j.actbio.2021.05.031. Epub 2021 May 31.
2
Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.载药介孔有机硅包覆四氧化三铁磁性纳米颗粒联合碘化油经导管动脉化疗栓塞抑制肝癌进展
J Colloid Interface Sci. 2021 Jun;591:211-220. doi: 10.1016/j.jcis.2021.02.022. Epub 2021 Feb 10.
3
Fabrication of FeO@PVA microspheres by one-step electrospray for magnetic resonance imaging during transcatheter arterial embolization.一步电喷雾法制备用于经导管动脉栓塞术的磁共振成像的 FeO@PVA 微球。
Acta Biomater. 2021 Sep 1;131:532-543. doi: 10.1016/j.actbio.2021.07.006. Epub 2021 Jul 7.
4
CT/MR detectable magnetic microspheres for self-regulating temperature hyperthermia and transcatheter arterial chemoembolization.CT/MR 可检测磁性微球用于自调节温度热疗和经导管动脉化疗栓塞。
Acta Biomater. 2022 Nov;153:453-464. doi: 10.1016/j.actbio.2022.09.054. Epub 2022 Sep 24.
5
Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization.载钽纳米颗粒的不透射线且均匀的海藻酸钠微球,用于经导管动脉栓塞术实时成像。
Theranostics. 2018 Aug 10;8(17):4591-4600. doi: 10.7150/thno.27379. eCollection 2018.
6
Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.基于磺胺甲噁唑的 pH 敏感水凝胶,具有经导管动脉化疗栓塞治疗的应用潜力。
Acta Biomater. 2016 Sep 1;41:253-63. doi: 10.1016/j.actbio.2016.05.018. Epub 2016 May 13.
7
Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor.多泡脂质体粒径对兔 VX2 肝肿瘤栓塞和治疗效果的影响。
Drug Deliv. 2023 Dec;30(1):1-16. doi: 10.1080/10717544.2022.2157519.
8
Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model.传统多柔比星经动脉栓塞化疗与载药栓塞经动脉化疗栓塞的比较:兔VX2肿瘤模型中的药物递送、药代动力学及治疗反应
Drug Deliv Transl Res. 2022 May;12(5):1105-1117. doi: 10.1007/s13346-021-00985-8. Epub 2021 Apr 16.
9
HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.针对 HIF-2α 的介入化疗栓塞多功能微球,用于有效消除肝细胞癌。
Biomaterials. 2022 May;284:121512. doi: 10.1016/j.biomaterials.2022.121512. Epub 2022 Apr 5.
10
Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.超声触发载药微泡联合经肝动脉化疗栓塞治疗兔 VX2 肝癌模型的构建及评价。
Theranostics. 2021 Jan 1;11(1):79-92. doi: 10.7150/thno.45348. eCollection 2021.

引用本文的文献

1
Practice revolution in local interventional therapy for liver metastases.肝脏转移瘤局部介入治疗的实践变革
ILIVER. 2025 Apr 23;4(2):100164. doi: 10.1016/j.iliver.2025.100164. eCollection 2025 Jun.
2
Efficacy and safety analysis of DEB-TACE for hepatocellular carcinoma with portal vein tumor thrombosis.载药微球经动脉化疗栓塞术治疗伴门静脉癌栓肝细胞癌的疗效及安全性分析
Discov Oncol. 2025 Jun 12;16(1):1064. doi: 10.1007/s12672-025-02927-z.
3
Nanomaterials for liver cancer targeting: research progress and future prospects.用于肝癌靶向的纳米材料:研究进展与未来展望
Front Immunol. 2025 Feb 28;16:1496498. doi: 10.3389/fimmu.2025.1496498. eCollection 2025.
4
Multi-stage mechanisms of tumor metastasis and therapeutic strategies.肿瘤转移的多阶段机制与治疗策略。
Signal Transduct Target Ther. 2024 Oct 11;9(1):270. doi: 10.1038/s41392-024-01955-5.
5
Polymeric Microspheres Designed to Carry Crystalline Drugs at Their Surface or Inside Cavities and Dimples.设计用于在其表面或腔内及凹坑处携带结晶药物的聚合物微球。
Pharmaceutics. 2023 Aug 15;15(8):2146. doi: 10.3390/pharmaceutics15082146.
6
Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer.基于纳米材料的抗血管生成疗法在癌症多模态治疗中的应用
Pharmaceutics. 2023 Apr 11;15(4):1207. doi: 10.3390/pharmaceutics15041207.
7
Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and Advances.作为治疗性栓塞程序载体系统的微球:成就与进展
J Clin Med. 2023 Jan 24;12(3):918. doi: 10.3390/jcm12030918.
8
Multimodal imaging of nano-assembled microspheres loaded with doxorubicin and Cisplatin for liver tumor therapy.负载阿霉素和顺铂的纳米组装微球用于肝脏肿瘤治疗的多模态成像
Front Bioeng Biotechnol. 2022 Sep 23;10:1024174. doi: 10.3389/fbioe.2022.1024174. eCollection 2022.